Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Melanoma Insights and Public Health Implications for Screening and Education in Low Mortality Populations
Description
The presentation focuses on melanoma insights and public health implications concerning screening and education in low-mortality populations, particularly minority groups. It highlights that while minority populations such as Black, Asian, and Hispanic individuals have lower melanoma mortality rates compared to non-Hispanic whites, they often face disparities in diagnosis and treatment, including advanced disease at diagnosis and delays in care. Although melanoma incidence is on the rise among these groups, invasive disease rates remain stable, suggesting a potential risk of overdiagnosis. The analysis points out the impracticality of broad screening protocols in low-risk populations and warns against overdiagnosis's psychological and procedural costs. It also emphasizes the need for targeted education in high-risk cohorts, despite the lack of identifiable genetic or epidemiological factors. Strategies to enhance outcomes include improving access to care, creating comprehensive registries for early invasive melanomas, enrolling more minority patients in clinical trials, and ensuring timely access to necessary treatments. The conclusion reinforces that while educational outreach is important, it should be approached cautiously to avoid exacerbating overdiagnosis issues.
View moreConclusions
- Minority populations have a significantly lower melanoma mortality compared to non-Hispanic whites.
- Screening for melanoma in low mortality populations is impractical due to high numbers needed to screen to prevent one death.
- There is an upward trend in melanoma in situ rates among minority populations, indicating potential overdiagnosis.
- Despite increased diagnoses of melanoma in situ in minority groups, invasive melanoma rates have remained stable, suggesting that early detection may not be affecting overall outcomes.
- There are significant disparities in access to care and treatment initiation for melanoma among minority populations, which affect outcomes.
- Educational initiatives to raise awareness about melanoma risks and symptoms in minority populations are critical and may be more effective than broad screening efforts.
- Collin M. Costello, MD, Stephen W. Dusza, DrPH, MPH, Ashfaq A. Marghoob, MD, Allan C. Halpern, MD. Melanoma screening and public education for minority populations in the United States. J Am Acad Dermatol. 2024 Jan;90(1):212-213. doi: 10.1016/j.jaad.2023.08.078. Epub 2023 Sep 4. PMID: 37666420.
- Kurtansky NR, Dusza SW, Halpern AC, Hartman RI, Geller AC, Marghoob AA, Rotemberg VM, Marchetti MA. An epidemiologic analysis of melanoma overdiagnosis in the United States, 1975-2017. J Invest Dermatol. 2022 Jul;142(7):1804-1811.e6. doi: 10.1016/j.jid.2021.12.003. Epub 2021 Dec 11. PMID: 34902365; PMCID: PMC9187775.
- Greene A, Iloabuchi VC, Stoos E, Butterfield RJ, Zhang N, Mangold AR, Leachman S, Costello CM. Increase in melanoma knowledge in Latino patients after a targeted digital educational program. JAAD Int. 2023 Nov 30;14:61-63. doi: 10.1016/j.jdin.2023.11.002. PMID: 38274397; PMCID: PMC10809116.
- Ramirez F, Alvarado L, Dwivedi A, Chacon J. Immunotherapy treatment disparities: A Texas cancer registry analysis of patients with cutaneous melanoma. J Immigr Minor Health. 2024 Feb;26(1):23-33. doi: 10.1007/s10903-023-01536-8. Epub 2023 Aug 24. Erratum in: J Immigr Minor Health. 2024 Feb;26(1):34. doi: 10.1007/s10903-023-01577-z. PMID: 37615821.
- Perez MI. Skin Cancer in Hispanics in the United States. J Drugs Dermatol. 2019 Mar 1;18(3):s117-120. PMID: 30909356.
- Sanchez DP, Maymone MBC, McLean EO, Kennedy KF, Sahni D, Secemsky EA, Vashi NA. Racial and ethnic disparities in melanoma awareness: A cross-sectional survey. J Am Acad Dermatol. 2020 Oct;83(4):1098-1103. doi: 10.1016/j.jaad.2020.04.137. Epub 2020 May 5. PMID: 32380221.